5 Recruiting Studies Using Alisertib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Alisertib
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
📍 Lucille Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California
Malignant Rhabdoid Tumor
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma
📍 Laura and Isaac Perlmutter Cancer Center at NYU Langone — New York, New York
Recurrent B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
HR+/HER2+ Breast Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
📍 Southern Cancer Center — Daphne, Alabama
Small Cell Lung Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
📍 Alabama Oncology — Birmingham, Alabama
Hormone Receptor Positive HER-2 Negative Breast Cancer
View Study & Checklist ➔